1
Study of TLR9 Agonist Vidutolimod (CMP-001) in Combination With Nivolumab vs. Nivolumab
Condition(s):MelanomaLast Updated:February 13, 2024Suspended
Hide Studies Not Open or Pending
Condition(s):MelanomaLast Updated:February 13, 2024Suspended
Condition(s):Melanoma Stage III; Melanoma Stage IVLast Updated:June 2, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.